Shares of Sareum Holdings Plc (LON: SAR) are up 491% this year largely due to the pharmaceutical company’s involvement in creating a drug to combat the most severe respiratory symptoms of COVID-19 and other viral infections.
The company recently received a £174,000 grant from the UK Research & Innovation (UKRI) to investigate the therapeutic potential of its SDC-1801 selective, small molecule TYK2/JAK1 kinase inhibitor to treat coronavirus.
John Reader, Sareum’s CEO said: “We are delighted that UKRI has indicated its conditional support for our programme to investigate the therapeutic potential of SDC-1801, our proprietary TYK2/JAK1 inhibitor, in severe phase [coronavirus]”
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Some investors may be wondering whether they should buy Sareum shares given their rally this year. Well, I’d like to point out that Sareum does not yet have a drug that is ready being sold in the market yet, and we could see a major rally in the stock once such a drug hits the market.
However, it might take a while for the SDC-1801 drug candidate to go through clinical trials and get regulatory approval for human use; we could get a major rally on such news.
Investors interested in the stock should keep this in mind when deciding whether or not to buy the company’s shares.
Sareum share price
People who read this also read:
